Lawrenceville, NJ, United States of America

Ying Jade Liu

This inventor holds 3 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Lexicon Pharmaceuticals, Inc.. Active years: 2012-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ying Jade Liu. Retrieved from https://idiyas.com/inventor/ying-jade-liu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 (Patent Applications = 2)

% Patents Active = 66.7

CIPO Patents = 1

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 10.0

ph-index = 2

Forward Citations = 12(Granted Patents)

Company Filing History:

3 out of 89

Lexicon Pharmaceuticals, Inc.

patents

Years Active: 2012-2015

Loading Chart...

3 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8969565 - Imidazo[1,2-b]pyridazine-based compounds, compositions comprising them, and methods of their use (2015-03-03),

2. 8450332 - LIMK2 inhibitors, compositions comprising them, and methods of their use (2013-05-28),

3. 8193202 - LIMK2 inhibitors, compositions comprising them, and methods of their use (2012-06-05),

Title: Innovations of Ying Jade Liu

Introduction

Ying Jade Liu is a notable inventor based in Lawrenceville, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patents. With a total of 3 patents, Liu's work focuses on compounds that have the potential to treat various diseases.

Latest Patents

Liu's latest patents include groundbreaking research on imidazo[1,2-b]pyridazine-based compounds. These compounds are designed to treat, manage, and prevent diseases mediated by adaptor associated kinase 1 activity. The patent details the specific formula of these compounds, where R, R, and R are defined within the documentation. Additionally, he has developed LIMK2 inhibitors, which are pharmaceutical compositions aimed at inhibiting LIM kinase 2 activity. These inhibitors also come with methods of use that enhance their therapeutic potential.

Career Highlights

Ying Jade Liu is currently associated with Lexicon Pharmaceuticals, Inc., where he continues to push the boundaries of pharmaceutical innovation. His work has been instrumental in advancing the understanding and treatment of various medical conditions.

Collaborations

Liu collaborates with talented professionals in his field, including Nicole Cathleen Goodwin and Bryce Alden Harrison. Their combined expertise fosters a productive environment for innovation and research.

Conclusion

Ying Jade Liu's contributions to the field of pharmaceuticals through his patents highlight his role as a significant inventor. His work not only showcases his innovative spirit but also has the potential to impact the treatment of various diseases.

Profile summary based on public USPTO records.